SCHEMBL7497799

SCHEMBL7497799

Cc1ccc2c(c1)c1c(CC(=O)N(C)C)nn(-c3ccccc3)c(=O)c1n2C

nearest known ligand 0.71

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.49
MAPT P10636 1/20 0.48
TP53 P04637 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22082635 0.92 TSPO (0.80) TSPOSMN1; SMN2MAPTTP53
SCHEMBL7750388 0.90 TSPO (0.56) TSPOSMN1; SMN2MAPTTP53KDM4E
SCHEMBL600372 0.89 TSPO (0.78) TSPOSMN1; SMN2MAPTTP53KDM4E
SCHEMBL7497769 0.85 TSPO (0.51) TSPOSMN1; SMN2MAPTTP53KDM4E
SCHEMBL197375 0.83 TSPO (1.00) TSPOMAPT
SCHEMBL7499582 0.83 TSPO (0.51) TSPOSMN1; SMN2MAPTTP53KDM4E
SCHEMBL8958820 0.81 TSPO (0.64) TSPOKDM4EALDH1A1HPGDTSHR
SCHEMBL7492444 0.81 TSPO (0.46) TSPOSMN1; SMN2MAPTTP53KDM4E
SCHEMBL10042107 0.80 TSPO (0.84) TSPOSMN1; SMN2MAPTTP53HPGD
SCHEMBL7750398 0.78 TSPO (0.69) TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000063-B1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI SYNTHELABO (FR) 2002-10-23 EP disclosed
US-6262045-B1 TREATMENT OF ANXIETY; SLEEP DISORDER; EPILEPSY; SPASTICITY; MUSCLE CONTRACTURE OR AN EXTRAPYRAMIDAL SYNDROM; INDUCING OR MAINTAINING ANAESTHESIA SANOFI-SYNTHELABO (FR) 2001-07-17 US disclosed